Biomarkers of fungal infection: Expert opinion on the current situation
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Bouza, E
- Almirante, B
- Rodriguez, JG
- Garnacho-Montero, J
- Munoz, P
- Sanguinetti, M
Grupos
Abstract
The introduction of non-culture-based diagnostic techniques is revolutionizing the world of microbiological diagnosis and infection assessment. Fungi are no exception, and the introduction of biomarkers has opened up enormous expectations for better management of these entities. Biomarkers are diverse, their targets are also diverse and their evaluation has been done preferably in an individualized use and with deficient designs. Less is known about the value of the combined use of biomarkers and the impact of the negativity of two or more biomarkers on antifungal treatment decisions has been poorly studied. Given the paucity of prospective, randomized and definitive studies, we have convened experts from different fields, with an interest in invasive fungal infections, to answer some questions about the current relevant use of fungal biomarkers. This document summarizes the answers of these experts to the different questions.
Datos de la publicación
- ISSN/ISSNe:
- 0214-3429, 1988-9518
- Tipo:
- Review
- Páginas:
- 1-10
- PubMed:
- 31729203
- Factor de Impacto:
- 0,430 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
Revista Espanola de Quimioterapia SOCIEDAD ESPANOLA QUIMIOTERAPIA
Citas Recibidas en Web of Science: 29
Documentos
- No hay documentos
Filiaciones
Keywords
- Invasive fungal infections; Intensive Care; Critical Care; Candidemia; Invasive candidiasis; invasive aspergillosis; fungal biomarkers; CAGTA; 1-3 beta-D-Glucan; Mannan; Anti-Mannan; T2Candida; Galactomannan; antifungal stewardship
Campos de Estudio
Cita
Bouza E,Almirante B,Rodriguez JG,Garnacho J,Salavert M,Munoz P,Sanguinetti M. Biomarkers of fungal infection: Expert opinion on the current situation. Rev Esp Quimioter. 2020. 33(1):p. 1-10. IF:1,553. (4).
Portal de investigación